Ask AI
ProCE Banner Activity

CME

Making Individualized ART Choices in Asia: How HIV-ASSIST Can Help

Video

Learn how to confidently make use of the HIV-ASSIST tool to select evidence-based ART regimens and individualize HIV treatment. Gain a solid understanding of HIV-ASSIST’s functionality and the data that validate its effectiveness. 

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Released: June 04, 2025

Expiration: June 03, 2026

Continue Activity

Share

Provided by

This educational activity is provided by Albert Einstein College of Medicine-Montefiore Medical Center in partnership with Clinical Care Options, LLC

ProCE Banner
ProCE Banner

Supporters

This program is supported by a medical education grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Partners

HIV-ASSIST

ProCE Banner

Target Audience

This activity is intended for healthcare professionals practicing in countries in Asia who prescribe antiretroviral therapy in the public or private sectors. 

Program Learning Goal

The goal of this activity is to improve learners’ awareness of, confidence in, and uptake of HIVASSIST to help guide individualized HIV treatment decisions in Asia.

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Confidently make use of the HIV-ASSIST tool based on a solid understanding of its functionality and the data that validate its effectiveness in HIV decision support

  • Select evidence-based ART regimens in common clinical scenarios through appropriate use of HIV-ASSIST

Disclosure

The “Policy on Identification, Mitigation, and Disclosure of Relevant Financial Relationships” of Albert Einstein College of Medicine-Montefiore Medical Center requires that any individual in control of content, including faculty, participating in CME activities disclose to the audience all relevant financial relationships with ineligible companies* in the past 24 months. Any individual in control of content who refuses to disclose, or whose disclosed relationships prove to create a conflict of interest, will be recused.

Individuals with the absence of relevant financial relationships with ineligible companies will be disclosed to the audience.

All financial relationships of individuals in a position to control the content of this CME activity are identified and mitigated prior to the educational activity.

*The ACCME defines an ineligible company as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Tanyaporn Wansom, MD, PhD, has no relevant financial relationships to disclose.

Content Reviewer:

Victor B. Hatcher, PhD does not have any relevant financial relationships with an ACCME-defined ineligible company in the last 24 months.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from June 04, 2025, through June 03, 2026:

  1. Login or Sign Up for an account by clicking at the top of this page.

  2. Read the target audience, learning objectives, and faculty disclosures.

  3. View and study the content in its entirety.

  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Albert Einstein College of Medicine-Montefiore Medical Center designates this other activity (blended live and enduring curriculum) for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.